RCUS logo

Arcus Biosciences (RCUS) Non Current Assets

Annual Non Current Assets

$134.00 M
-$130.00 M-49.24%

December 31, 2024

Summary

Performance

1-Year Change

-49.24%

3-Year Change

-59.39%

5-Year Change

+1187.84%

15-Year Change

+884.06%

RCUS Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

71.39%
RCUS annual long term assets is higher than 71.39% of companies in Healthcare sector

High & Low

All-time High

$330.00 M
RCUS annual long term assets is currently -59.39% below its historical high of $330.00 million

3-Year Low

$134.00 M
RCUS annual long term assets is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
RCUS previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
RCUS next annual earnings announcement has not yet been scheduled

OtherRCUSbalance sheetmetrics:

Annual Total Assets

$1.15 B
RCUS annual total assets is $1.15 billion

Annual Current Assets

$1.02 B
RCUS annual total current assets is $1.02 billion

Annual Total Liabilities

$665.00 M
RCUS annual total liabilities is $665.00 million

Annual Total Long Term Liabilities

$439.00 M
RCUS annual total long term liabilities is $439.00 million

Quarterly Non Current Assets

$134.00 M
+$9.00 M+7.20%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-49.24%

3-Year Change

-59.39%

5-Year Change

+1187.84%

RCUS Quarterly Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

71.59%
RCUS quarterly long term assets is higher than 71.59% of companies in Healthcare sector

High & Low

All-time High

$330.00 M
RCUS quarterly long term assets is currently -59.39% below its historical high of $330.00 million

3-Year Low

$125.00 M
RCUS quarterly long term assets is currently +7.20% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
RCUS previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
RCUS next earnings announcement is scheduled for May 8, 2025

OtherRCUSbalance sheetmetrics:

Quarterly Total Assets

$1.15 B
RCUS quarterly total assets is $1.15 billion

Quarterly Current Assets

$1.02 B
RCUS quarterly total current assets is $1.02 billion

Quarterly Total Liabilities

$665.00 M
RCUS quarterly total liabilities is $665.00 million

Quarterly Long Term Liabilities

$439.00 M
RCUS quarterly total long term liabilities is $439.00 million

Non Current Assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

RCUS Non Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-49.2%-49.2%
3 y3 years-59.4%-59.4%
5 y5 years+1187.8%+1187.8%

RCUS Non Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-59.4%at low-59.4%+7.2%
5 y5-year-59.4%+1187.8%-59.4%+1268.7%
alltimeall time-59.4%+1238.5%-59.4%+1268.7%

Arcus Biosciences Non Current Assets History

DateAnnualQuarterly
Dec 2024
$1.02 B(+22.3%)
$134.00 M(+7.2%)
Sep 2024
-
$125.00 M(-23.8%)
Jun 2024
-
$164.00 M(-28.4%)
Mar 2024
-
$229.00 M(-13.3%)
Dec 2023
$831.00 M(-22.1%)
$264.00 M(-14.6%)
Sep 2023
-
$309.00 M(+32.1%)
Jun 2023
-
$234.00 M(-2.1%)
Mar 2023
-
$239.00 M(-14.0%)
Dec 2022
$1.07 B(-15.5%)
$278.00 M(-5.0%)
Sep 2022
-
$292.71 M(+17.4%)
Jun 2022
-
$249.30 M(-10.7%)
Mar 2022
-
$279.20 M(-15.4%)
Dec 2021
$1.26 B
$330.00 M(+12.2%)
Sep 2021
-
$294.00 M(+92.4%)
Jun 2021
-
$152.82 M(+63.9%)
DateAnnualQuarterly
Mar 2021
-
$93.25 M(+155.6%)
Dec 2020
$735.82 M(+281.8%)
$36.48 M(+162.9%)
Sep 2020
-
$13.88 M(+41.7%)
Jun 2020
-
$9.79 M(-1.4%)
Mar 2020
-
$9.93 M(-4.6%)
Dec 2019
$192.71 M(-25.6%)
$10.40 M(-36.8%)
Sep 2019
-
$16.47 M(+46.5%)
Jun 2019
-
$11.24 M(-16.8%)
Mar 2019
-
$13.52 M(-15.4%)
Dec 2018
$258.95 M(+46.4%)
$15.98 M(-25.5%)
Sep 2018
-
$21.44 M(-18.9%)
Jun 2018
-
$26.42 M(+13.3%)
Mar 2018
-
$23.33 M(+71.3%)
Dec 2017
$176.87 M(+77.4%)
$13.62 M
Dec 2016
$99.69 M
-

FAQ

  • What is Arcus Biosciences annual long term assets?
  • What is the all time high annual non current assets for Arcus Biosciences?
  • What is Arcus Biosciences annual non current assets year-on-year change?
  • What is Arcus Biosciences quarterly long term assets?
  • What is the all time high quarterly non current assets for Arcus Biosciences?
  • What is Arcus Biosciences quarterly non current assets year-on-year change?

What is Arcus Biosciences annual long term assets?

The current annual non current assets of RCUS is $134.00 M

What is the all time high annual non current assets for Arcus Biosciences?

Arcus Biosciences all-time high annual long term assets is $330.00 M

What is Arcus Biosciences annual non current assets year-on-year change?

Over the past year, RCUS annual long term assets has changed by -$130.00 M (-49.24%)

What is Arcus Biosciences quarterly long term assets?

The current quarterly non current assets of RCUS is $134.00 M

What is the all time high quarterly non current assets for Arcus Biosciences?

Arcus Biosciences all-time high quarterly long term assets is $330.00 M

What is Arcus Biosciences quarterly non current assets year-on-year change?

Over the past year, RCUS quarterly long term assets has changed by -$130.00 M (-49.24%)